See inflammation at the
protein level.
The NULISAseq Inflammation Panel 250 delivers the deepest profiling of inflammatory response — measuring 250 low-abundance proteins with unprecedented sensitivity to reveal the molecular drivers of aging and disease years early.
Why This Matters
Chronic inflammation is the shared root of heart disease, diabetes, cancer, and dementia.
Most inflammatory drivers move in vanishingly small concentrations — invisible to conventional tests. The NULISAseq Inflammation Panel 250 measures them with unmatched detectability.
250+
Inflammation Proteins
The most comprehensive coverage of immune response in a single panel — measured from as little as 10µL of sample (25µL input).
Attomolar
Sensitivity
NULISA technology measures proteins down to fg/mL levels, surfacing baseline signals of low-abundance cytokines other assays cannot see.
12 logs
Dynamic Range
A 12-log dynamic range without dilution captures both abundant and vanishingly rare proteins in the same measurement.
<10%
Coefficient of Variation
Highly reproducible results, intra- and inter-plate — precision you can track confidently over time.
Unmatched Detectability
See biomarkers other technologies miss — the faint, low-abundance proteins where the earliest signals of disease emerge.
Detectability
Beyond a single marker — into the whole inflammatory system.
Conventional inflammation tests read one or two abundant markers — a narrow window into a complex system. The NULISAseq Inflammation Panel 250 resolves 250 proteins with attomolar sensitivity, surfacing the signals others cannot see.
Conventional Inflammation Markers
CRP and ESR markers
Single-cytokine assays
Limited dynamic range
Misses low-abundance signals
A narrow view. Misses the earliest signals.
With NULISAseq Panel 250
250 inflammation proteins
Attomolar sensitivity
12-log dynamic range, no dilution
Sees what others miss
The deepest profiling of inflammatory response.
Research & Clinical Areas
Where deep inflammation profiling matters most.
The panel spans the conditions where the earliest molecular signals of inflammation shape outcomes — from autoimmune disease to the inflammaging that drives every system of the body.
- Autoimmune Disease
Profile the immune dysregulation underlying autoimmune conditions with the breadth to separate signal from noise.
- Neuroinflammation
Detect neuroinflammatory signatures through low-abundance proteins linked to the aging and disease of the brain.
- Immuno-Oncology
Characterize the inflammatory microenvironment with the sensitivity to track subtle immune shifts.
- Cardiometabolic Health
Map the chronic inflammation that drives cardiovascular and metabolic disease before it becomes clinical.
- Inflammaging
Quantify the inflammation-driven aging process that quietly accelerates the body across every system.
Your care team helps you place each result in the context of your broader health.
The Full Picture
Deep inflammation profiling is one layer of a complete longevity system.
Human Longevity members receive an integrated view of health that combines whole genome sequencing, whole body MRI, 100+ biomarkers, and Longevity AI — with the NULISAseq Inflammation Panel 250 adding the deepest available read on the inflammatory drivers of aging and disease.
An HLI offering, powered by Alamar Biosciences' NULISA technology.